Global Cell Analysis Market Size By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells, Microbial Cells), By End-User (Biotechnology Companies, Hospitals, Cell Banks), By Geographic Scope And Forecast
세포 분석 시장 규모 및 예측
세포 분석 시장 규모는 2021년 160억 7,000만 달러로 평가되며, 2023년부터 2030년까지 10.15%의 CAGR로 성장하여 2030년에는 383억 4,000만 달러에 달할 것으로 예상됩니다. 세포 기반 연구에 대한 정부 자금의 증가는 시장 성장을 촉진하는 단일세포 분석 제품의 기술 발전뿐만 아니라 세포 분석의 시장 수익 증가의 중요한 측면입니다. 세포 분석 세계 시장 보고서는 시장의 전반적인 평가를 제공합니다. 주요 부문, 동향, 시장 촉진요인, 억제요인, 경쟁 상황, 시장에서 중요한 역할을 하는 요인 등을 포괄적으로 분석합니다.
세계 세포 분석 시장의 정의
세포 분석은 단일 세포 수준에서 생물의 유전체, 대사체학, 전사체학, 단백체학을 연구합니다. 단일세포 분석은 인간 유전체를 단일 세포의 이질성으로 측정, 분석, 염기서열 분석할 때 사용됩니다. 형광 활성화 세포 분류는 복잡한 시료에서 선택된 단일 세포를 분리합니다. 임상 진단에서 세포 분석은 암의 실시간 모니터링을 위한 귀중한 정보, 그리고 궁극적으로 환자의 이익을 위한 새로운 치료 전략을 위해 워크플로우를 표준화하고 자동화할 수 있을 것으로 기대됩니다.
세포 분석은 유전자 식별, 단백질 식별, 후성유전체학 및 기타 생명과학 관련 분야에서 필수적인 요소입니다. 세포 이미징 및 분석 시스템의 정확도 향상은 신약 개발 프로세스의 시간 단축과 비용 절감에 도움이 됩니다. 오늘날 대부분의 장소에서 세포는 샘플 당 수천 개의 세포로 대량으로 분석되며, 결과는 세포의 평균 반응을 기반으로 분석됩니다. 따라서 실용적이고 정확한 세포 분석을 위해서는 개별 세포가 정확히 어떻게 반응하는지를 고려하는 것이 필수적입니다.
세계 세포 분석 시장 개요
세포 분석 시장의 발전은 헬스케어 산업의 발전과 암 발병률의 증가가 원동력이 되고 있습니다. 또한, 기술적으로 진보된 제품의 도입과 병원, 진단 연구소 등의 증가는 시장 성장을 촉진하고 있습니다. 또한, 진단 애플리케이션에 대한 세포 분석의 채택이 증가하고 있는 것도 세계 세포 분석 시장 개척을 촉진하는 중요한 요인으로 작용하고 있습니다. 또한, 세포 기반 연구에 대한 정부의 투자 및 자금 조달 증가는 세계 시장 성장을 촉진하는 또 다른 요인입니다.
또한, 감염성 질환, 만성질환, 신경 질환의 유병률 증가는 세포 분석 세계 시장 성장을 촉진하는 긍정적인 예측이 되고 있습니다. 전체 시장의 성장을 저해하는 요인도 있습니다. 높은 장비 비용 등의 요인이 시장 성장을 저해하고 있습니다. 또한, 소규모 기업 및 신규 진입 기업의 생존도 시장이 직면한 큰 과제입니다. 그러나 체세포 연구와 세포 시퀀싱의 연구개발은 세계 세포 분석 시장 내 주요 업체들에게 유리한 비즈니스 기회를 제공할 것으로 예상됩니다.
목차
제1장 세계의 세포 분석 시장 소개
제2장 주요 요약
제3장 VERIFIED MARKET RESEARCH 조사 방법
- 데이터 마이닝
- 밸리데이션
- 1차 자료
- 데이터 소스 리스트
제4장 세계의 세포 분석 시장 전망
- 개요
- 시장 역학
- Porter's Five Forces 모델
- 밸류체인 분석
- 규제 프레임워크
제5장 세포 분석 세계 시장 : 제품별
- 개요
- 소모품
- 검사 기기
- 현미경
- 유세포 분석
- 분광광도계
- qPCR
- 셀 카운터
- HCS 시스템
- 세포 마이크로어레이
제6장 세계의 세포 분석 시장 : 세포 유형별
제7장 세계의 세포 분석 시장 : 최종사용자별
- 개요
- 바이오테크놀러지 기업
- 병원
- 세포은행
- 기타
제8장 세포 분석 세계 시장 : 지역별
- 개요
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 세계 기타 지역
제9장 세계의 세포 분석 시장 경쟁 구도
- 개요
- 기업 시장 점유율
- 벤더 상황
- 주요 발전 전략
제10장 기업 개요
- Becton, Dickinson and Company
- Merck KGAA
- Thermo Fisher Scientific, Inc.
- Danaher Corporation
- GE Healthcare
- Agilent Technologies, Inc.
- Olympus Corporation
- Perkinelmer, Inc.
- Promega Corporation
- Tecan Group Ltd.
제11장 주요 발전
- 제품 출시/개발
- 인수합병
- 사업 확대
- 파트너십과 제휴
제12장 부록
ksm
Cell Analysis Market Size And Forecast
Cell Analysis Market size was valued at USD 16.07 Billion in 2021 and is projected to reach USD 38.34 Billion by 2030 , growing at a CAGR of 10.15% from 2023 to 2030. The increasing government funding for cell-based research is the crucial aspect of the rise in the market revenue of Cell Analysis as well as the technological advancements in single-cell analysis products that will foster market growth. The Global Cell Analysis Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Cell Analysis Market Definition
Cell Analysis studies the genomics, metabolomics, transcriptomics, and proteomics of a living being at a single-cell level. The single-Cell Analysis is used in measuring, analyzing, and sequencing the human genome at a single-cell heterogeneity. Fluorescence-activated cell sorting isolates the selected single cells from complex samples. In clinical diagnostics, Cell Analysis is expected to standardize and automate workflows with valuable information for real-time monitoring of cancer and, eventually, new therapeutic strategies for the benefit of patients.
Cellular Analysis is vital in gene identification, protein identification, epigenomics, and other life science-related areas. Enhanced accuracy of cell imaging and analysis systems helps reduce the drug discovery process time and price. Today in most places, cells are analyzed in masses with thousands of cells per sample, and results are analyzed based on the average response of the cells. Hence to get practical and accurate Cell Analysis, it's essential to review how exactly individual cells respond.
Global Cell Analysis Market Overview
The Growth of the Cell Analysis Market is driven by the development of the healthcare industry and the rise in cancer incidence. Furthermore, the introduction of technologically advanced products and an increased number of hospitals, diagnostic laboratories, and others fuel the market growth. Moreover, increasing the adoption of Cell Analysis for diagnostic applications is a significant factor driving the development of the global Cell Analysis Market. Moreover, rising government investments and funding for cell-based research are other factors fueling the growth of the worldwide market.
Moreover, the increasing prevalence of infectious & chronic diseases and neurological disorders has positively anticipated propelling the growth of the global Cell Analysis Market. There are specific challenges faced that will hinder the overall market growth. Factors such as the high cost of instruments inhibit the market's growth. Also, the survival of small players and new entrants is the major challenge faced by the market. However, research and development in somatic cell research and cell sequencing may be expected to present lucrative business opportunities for major players within the global Cell Analysis Market.
Global Cell Analysis Market Segmentation Analysis
The Global Cell Analysis Market is segmented based on Product, Cell Type, End-User, And Geography.
Cell Analysis Market, By Product
Based on Product, the market is bifurcated into Consumables and Instruments. The consumables segment holds the largest market share during the forecast period. The factors that can be attributed to the frequent purchase of these products as compared to instruments, which are considered as a one-time investment, and their wide applications in research and genetic exploration, exosome analysis, and isolation of RNA and DNA are accelerating the demand for consumables segment.
Cell Analysis Market, By Cell Type
- Human Cells
- Animal Cells
- Microbial Cells
Based on Cell Type, the market is bifurcated into Human Cells, Animal Cells, and Microbial Cells. The human cells segment holds the largest market share. The factors that can be attributed to the high utilization of human cells in research laboratories and academic institutes are accelerating the demand.
Cell Analysis Market, By End-User
- Biotechnology Companies
- Hospitals
- Cell Banks
- Others
Based on End-User, the market is bifurcated into Biotechnology Companies, Hospitals, Cell Banks, and Others. The academic and research laboratories segment holds the largest market share during the forecast period. The factors that can be attributed to growth in funding for all times science research and therefore the increasing number of medical colleges and universities enhance the demand for academic and research laboratories segment.
Cell Analysis Market, By Geography
- North America
- Europe
- Asia Pacific
- Rest of The World
- On the basis of Geography, the Global Cell Analysis Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Asia-Pacific holds the largest market share. The Asia Pacific market is anticipated to witness the highest growth during the forecast period. The presence of a large patient population (especially in China and India), increasing investments in R&D, growth in the outsourcing of drug discovery services to Asian CROs, strong governmental initiatives, and ongoing projects will boost the market in the APAC region.
Key Players
- The "Global Cell Analysis Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are
- Becton, Dickinson and Company, Merck KGAA, Thermo Fisher Scientific, Inc., Danaher Corporation, GE Healthcare, Agilent Technologies, Inc., Olympus Corporation, Perkinelmer, Inc., Promega Corporation, and Tecan Group Ltd.
Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.
Key Developments
- Product Launches and Product Expansions
- In April 2018, BD (Becton, Dickinson and Business), a leading worldwide medical technology company, announced the launch of the BD FACSymphony(TM) S6 cell sorter, which will be on exhibit at the 33rd Congress of the International Society for Advancement of Cytometry next week in Prague. The new platform takes advantage of the BD FACSymphony cell analyzer's high parameter capabilities, allowing researchers to sort cell populations to better understand cell phenotypes for immunology and multi-omics research.
- In May 2018, Beckman Coulter Life Sciences introduced the Kaluza C Flow Cytometry Analysis Software, a sophisticated data analysis system for clinical laboratories. The new program simplifies clinical QC reporting and addresses flow cytometry standardization difficulties.
- In September 2018, Leica Microsystems established the first Imaging Center in San Francisco. This facility will showcase the spectrum of technology in microscopes produced by Leica Microsystems for life sciences research.
TABLE OF CONTENTS
1 INTRODUCTION OF GLOBAL CELL ANALYSIS MARKET
- 1.1 Overview of the Market
- 1.2 Scope of Report
- 1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List of Data Sources
4 GLOBAL CELL ANALYSIS MARKET OUTLOOK
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 4.5 Regulatory Framework
5 GLOBAL CELL ANALYSIS MARKET, BY PRODUCT
- 5.1 Overview
- 5.2 Consumables
- 5.2.1 Reagents
- 5.2.2 Assay Kits
- 5.2.2.1 Immuno assays
- 5.2.2.2 Cell based assays
- 5.2.3 Microplates
- 5.2.4 Others
- 5.3 Instruments
- 5.3.1 Microscopes
- 5.3.2 Flow cytometry
- 5.3.3 Spectrophotometers
- 5.3.4 qPCR
- 5.3.5 Cell Counters
- 5.3.6 HCS Systems
- 5.3.7 Cell Microarrays
6 GLOBAL CELL ANALYSIS MARKET, BY CELL TYPE
- 6.1 Overview
- 6.2 Human Cells
- 6.3 Animal Cells
- 6.4 Microbial Cells
7 GLOBAL CELL ANALYSIS MARKET, BY END-USER
- 7.1 Overview
- 7.2 Biotechnology Companies
- 7.3 Hospitals
- 7.4 Cell Banks
- 7.5 Others
8 GLOBAL CELL ANALYSIS MARKET, BY GEOGRAPHY
- 8.1 Overview
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Argentina
- 8.6 Rest of the World
- 8.6.1 Middle East and Africa
9 GLOBAL CELL ANALYSIS MARKET COMPETITIVE LANDSCAPE
- 9.1 Overview
- 9.2 Company Market Share
- 9.3 Vendor Landscape
- 9.4 Key Development Strategies
10 COMPANY PROFILES
- 10.1 Becton, Dickinson and Company
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
- 10.2 Merck KGAA
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
- 10.3 Thermo Fisher Scientific, Inc.
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
- 10.4 Danaher Corporation
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
- 10.5 GE Healthcare
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
- 10.6 Agilent Technologies, Inc.
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
- 10.7 Olympus Corporation
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
- 10.8 Perkinelmer, Inc.
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
- 10.9 Promega Corporation
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
- 10.10 Tecan Group Ltd.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
11 KEY DEVELOPMENTS
- 11.1 Product Launches/Developments
- 11.2 Mergers and Acquisitions
- 11.3 Business Expansions
- 11.4 Partnerships and Collaborations
12 Appendix
